Upgrade to SI Premium - Free Trial

Nanometrics, Inc. (NANO)

35.33 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Latest Headlines

NANOBIOTIX closes global offering, raises $100 million May 26, 2026 4:51 PM - StreetInsider NANOBIOTIX Announces Closing of Global Offering May 26, 2026 4:44 PM - Globe NewsWire Nanobiotix Announces Pricing of Oversubscribed €85m Global Offering May 21, 2026 10:57 AM - Globe NewsWire Nanobiotix reports early lung cancer trial data for JNJ-1900 treatment May 17, 2026 10:15 AM - StreetInsider Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer May 17, 2026 10:15 AM - Globe NewsWire Nanobiotix announces FDA accepts protocol changes to cancer study May 4, 2026 5:29 PM - StreetInsider Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study May 4, 2026 5:29 PM - Globe NewsWire NANOBIOTIX Statement Regarding Recent Media Speculation March 25, 2026 10:11 AM - Globe NewsWire Form 6-K Nanobiotix S.A. For: Mar 12 March 12, 2026 4:35 PM - SEC Filing Full Article List